6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Accumulating evidence indicates that the senescence-associated secretory phenotype (SASP) contributes to many aspects of physiology and disease. Thus, controlling the SASP will have tremendous impacts on our health. However, our understanding of SASP regulation is far from complete. Here, we show that cytoplasmic accumulation of nuclear DNA plays key roles in the onset of SASP. Although both DNase2 and TREX1 rapidly remove the cytoplasmic DNA fragments emanating from the nucleus in pre-senescent cells, the expression of these DNases is downregulated in senescent cells, resulting in the cytoplasmic accumulation of nuclear DNA. This causes the aberrant activation of cGAS-STING cytoplasmic DNA sensors, provoking SASP through induction of interferon-β. Notably, the blockage of this pathway prevents SASP in senescent hepatic stellate cells, accompanied by a decline of obesity-associated hepatocellular carcinoma development in mice. These findings provide valuable new insights into the roles and mechanisms of SASP and possibilities for their control.

          Related collections

          Author and article information

          Journal
          Nat Commun
          Nature communications
          Springer Science and Business Media LLC
          2041-1723
          2041-1723
          Mar 28 2018
          : 9
          : 1
          Affiliations
          [1 ] The Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, 135-8550, Japan.
          [2 ] PRESTO, JST, Kawaguchi, Saitama, 332-0012, Japan.
          [3 ] Faculty of Science & Technology, Tokyo University of Science, Noda-shi, Chiba, 278-8510, Japan.
          [4 ] Research Institute for Microbial Diseases, Osaka University, Suita-shi, Osaka, 565-0871, Japan.
          [5 ] Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
          [6 ] Graduate School of Medicine, Osaka City University, Abeno-ku, Osaka, 545-8585, Japan.
          [7 ] The Cancer Institute, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, 135-8550, Japan. ehara@biken.osaka-u.ac.jp.
          [8 ] Research Institute for Microbial Diseases, Osaka University, Suita-shi, Osaka, 565-0871, Japan. ehara@biken.osaka-u.ac.jp.
          Article
          10.1038/s41467-018-03555-8
          10.1038/s41467-018-03555-8
          5871854
          29593264
          85a10ff6-222c-47f6-9cdc-e6952a694faa
          History

          Comments

          Comment on this article